Tofacitinib for Rheumatoid Arthritis and Plaque Psoriasis Tofacitinib for Rheumatoid Arthritis and Plaque Psoriasis

Review the latest data on the oral immunosuppressant tofacitinib, recently approved for the treatment of rheumatoid arthritis, and currently in Phase III trials for treating chronic plaque psoriasis.Skin Therapy Letter
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news